« Back to Record
Citation APA

Vincent, J. L., François, B., Zabolotskikh, I., Daga, M., Lascarrou, J. B., Kirov, M. M., Pettilä, V., Wittebole, X., Meziani, F., Mercier, E., Lobo, S. M., Barie, P. S., Crowther, M., Esmon, C. C., Fareed, J., Gando, S., Gorelick, K. K., Levi, M., Mira, J.-P., Opal, S., Parrillo, J. J., Russell, J., Saito, H., Tsuruta, K., Sakai, T., & Fineberg, D. (2019). Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients with Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA (Chicago, Ill.), 321(20), 1993-2002. doi:10.1001/jama.2019.5358


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/289631

Vincent, J. L., François, B., Zabolotskikh, I., Daga, M., Lascarrou, J. B., Kirov, M. M., Pettilä, V., Wittebole, X., Meziani, F., Mercier, E., Lobo, S. M., Barie, P. S., Crowther, M., Esmon, C. C., Fareed, J., Gando, S., Gorelick, K. K., Levi, M., Mira, J.-P., Opal, S., Parrillo, J. J., Russell, J., Saito, H., Tsuruta, K., Sakai, T., & Fineberg, D. (2019). Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients with Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA (Chicago, Ill.), 321(20), 1993-2002. doi:10.1001/jama.2019.5358